← Back to Clinical Trials
Recruiting NCT06934564

De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

Trial Parameters

Condition Breast Lumpectomy
Sponsor University of Michigan
Study Type INTERVENTIONAL
Phase N/A
Enrollment 16
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2026-12
Interventions
Active de-Implementation

Brief Summary

This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.

Eligibility Criteria

Site Inclusion Criteria: * Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair) Exclusion Criteria: * none Surgical participants must be over 18 years old.

Related Trials